Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chondrocyte Alginate Gel Suspension in Pediatric Vesicoureteral Reflux
NCT00004487Phase 3Unknown
- Sponsor
- Food and Drug Administration
- Start
- May 1999
- Modality
- Hydrogel Systems, Cell Therapies
01
Overview
A Phase 3 trial of Chondrocyte-alginate gel suspension in vesicoureteral reflux (VUR), sponsored by Food and Drug Administration. Status: unknown.
02
Drugs
Chondrocyte-alginate gel suspension
03
Conditions
vesicoureteral reflux (VUR)
Beyond the preview
Go deeper on NCT00004487.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00004487.